BioPharma
12 March, 2026 | Thursday | Opinion
2026: AI Transforms China’s Pharma Sector and Drives More Strategic M&A Deals
The preceding decade was marked by rapid growth and robust policy backing; however, the landscape has fundamentally evolved. Research and development expenses persist in escalating, competition has intensified ...
Lab
12 March, 2026 | Thursday | News
Eurofins Biomnis Develops LC MS MS Method For Detecting Cereulide Toxin In Human Stool Samples
Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new ...
BioTech
06 March, 2026 | Friday | News
Thermo Fisher Opens Cryo Electron Microscopy Drug Discovery Center In South San Francisco
Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco. The new center provides ...
Contract Services
13 March, 2026 | Friday | News
Locus Cell And Charles River Sign Strategic MoU To Advance Cell And Gene Therapy Manufacturing In APAC
Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles River Laboratories ("Charles River"), a global contract re...
Consumer Health
10 March, 2026 | Tuesday | News
China Clears IND For Harbour BioMed And Kelun Biotech Bispecific Antibody For Atopic Dermatitis
Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Kelun-Biotech (6990.HK) today announced...
White Paper
05 March, 2026 | Thursday | Analysis
What happens when Mucinex and Sudafed are taken together?
Product Spot Light
11 March, 2026 | Wednesday | News
Waters Corporation Launches ARES G3 Rheometer To Accelerate Materials Research And Testing
Premium Article
15 December, 2025 | Tuesday | Report
APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
Bio Invest
12 March, 2026 | Thursday | News
Curatis Partners With Neupharma To Advance Corticorelin Development For Brain Tumour Related Edema In Japan
Biopharma APAC Infomercial
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
